proteomics

Alamar Biosciences, Inc. is a proteomics company based in Fremont, California, that develops technologies for protein biomarker detection. Its offerings include the ARGO HT System, an all-in-one automated instrument with onboard qPCR, and NULISA assays for immunology, neurology, and oncology, along with custom assay development and data analysis solutions.

Automationcustom assay developmentData Analysismultiplex biomarker analysisNGSqPCRsingle-plex assays

AltraBio is a contract research company specializing in advanced biological data analysis and bioinformatics services, helping biopharma, cosmetic, and clinical R&D organizations extract insights from cytometry, omics, and medical data using AI, machine learning, and biostatistics. It serves pharmaceutical companies, biotech startups, dermo-cosmetic leaders, and university hospitals worldwide.

automated gatingbioinformatics pipeline developmentbiomarker discoverybiostatisticsbulk transcriptomicscytometry data analysishigh-dimensional panel analysismachine learningpatient stratificationreal-world data miningsingle-cell RNA-seq analysisstatistical modelingtarget identification

AmberGen is a privately held, Boston-area company founded in 1993 to commercialize photonic technology developed at Boston University. It combines patented techniques in proteomics, mass spectrometry and light-based control of biomolecules to innovate in spatial biology, diagnostics and therapeutics. Its MaxOmic Laboratory provides multiomic spatial biology imaging and analysis services, and it offers Miralys MALDI-IHC imaging reagents, probes, panels and antibody conjugation kits.

antibody conjugationMALDI-IHC spatial biology imagingmass spectrometry imagingmultiomic imaging and analysis servicesphotocleavable mass-tag labeling

BEVITAL AS is a non-profit organization based in Bergen, Norway, providing high-precision targeted metabolomics and proteomics services for scientists since 2003. Its analytical platforms use authentic isotope-labelled internal standards for each analyte, quantifying metabolites across physiologically relevant ranges in serum, plasma, or CSF. It offers pre-designed panels and customized assays, plus Olink proteomics and multiomics services.

GC-MS/MSLC-MS/MSmethod developmentmultiomics data integrationOlink proteomicsstatistical analysistargeted metabolomics

BloodScan Biotech is a life science technology company pioneering a liquid biopsy platform based on circulating tumor cells (CTCs). Its flagship system, Labyrinth One, isolates intact and viable CTCs from a simple blood draw, delivering tissue-biopsy-equivalent insights non-invasively for cancer detection from stage 0 through advanced disease, treatment monitoring, and precision oncology research. The technology builds on over a decade of development and is validated by more than 15 peer-reviewed publications.

automated CTC isolationcell culturegenomicshistologylabel-free microfluidic CTC isolationliquid biopsysingle-cell sequencing

Bridging Pieces is a Certified Small Business (CAGE Code 9DF83) focused on state and federal contracts, serving local, state, and federal government agencies as well as commercial and industrial clients. It offers a one-stop-shop of contracting services including general construction, HVAC, plumbing, logistics, courier, pest control, janitorial, non-destructive testing, biotechnology/genomics, IT solutions, and website design, development, and hosting.

Automated Ultrasonic Testing (AUT)Corrosion MappingDigital Radiography (DR/RTR)Liquid Penetrant Testing (PT)Magnetic Particle Testing (MT)metabolomicsMulti-omics and genomic testingnon-destructive testing (NDT)Phased Array UT (PAUT)Positive Material Identification (PMI)Radiographic Testing (RT)Time of Flight Diffraction (TOFD)Ultrasonic Shear WaveUltrasonic Testing (UT)Visual Testing (VT)

Captis Diagnostics develops extracellular vesicle (EV) isolation technology for minimally invasive human disease research and clinical diagnostics. Its Lipid Nanoprobe (LNP) platform enables rapid, high-efficiency EV isolation from human biofluids in 15 minutes or less without ultracentrifugation, supporting DNA mutation detection, RNA sequencing, and proteomics from a single blood draw. The company also offers precision EV isolation kits for multi-omics discovery and proteomics workflows.

DNA mutation detectionepigenomic profilingextracellular vesicle isolationliquid biopsymagnetic separationnext generation sequencingRNA sequencing

CeleramAb Inc. is a Madison, Wisconsin biotechnology company founded in October 2024 by Professors Joshua Coon and Lloyd Smith under an exclusive license agreement with the Wisconsin Alumni Research Foundation (WARF). It develops the RaPiD-mAb-MS™ platform to accelerate antibody characterization and peptide mapping by eliminating the traditional liquid chromatography bottleneck, claiming a 50X throughput increase and >2X cost reduction.

antibody characterizationautomated data analysismass spectrometrypeptide mapping

CSIR-CCMB is a premier research organization in frontier areas of modern biology, based in Hyderabad, Telangana, India. It addresses fundamental questions in biology and develops technology from basic research findings toward unmet societal needs, creating novel solutions in medicine, agriculture and wildlife conservation.

Advanced Microscopy and Cell SortingAnimal Biosafety Level-3 LabAutomated DNA SequencingAutomated Karyotypingbioinformaticscell cultureDNA Microarrayflow cytometryIntegrative Structural Biologynext generation sequencingspectroscopyTransgenic FacilityZebrafish Laboratory

The Istituto di Ricerca Genetica e Biomedica (IRGB) is a research institute of the Consiglio Nazionale delle Ricerche (CNR), with main offices in Monserrato (Cagliari) and secondary sites in Lanusei, Milan and Sassari. It conducts basic and translational research in genetics and biomedical genomics, including rare genetic diseases, cardiovascular diseases, regenerative medicine and oncology.

bioinformatics/high-performance computingcell biologycytogeneticsgenomicsgenotypingliquid biopsymolecular biologymolecular diagnosticsNGS sequencing

CuriRx, Inc. is a pharmaceutical CRDMO based in Wilmington, Massachusetts, providing a broad range of services to pharmaceutical companies of all sizes. Its services include formulation, prefilled syringes, lyophilization, nanotechnology, advanced bioprocessing, cell line and strain development, upstream and downstream process development, and analytical services through its CuriLytics platform.

analytical method developmentbioprocessingcell line and strain developmentdownstream process developmentformulationhigh-resolution mass spectrometrylyophilizationnanotechnologyqualification and validationstability testingupstream process development

Cx Precision Medicine (CxPM) is an AI-driven diagnostics company developing blood tests that use a predictive algorithm and proteomics to rule out neurodegenerative disorders such as Alzheimer's Dementia and Parkinson's Disease in patients with early symptoms in primary care. Its NeuroFirst™ Memory test is a blood test to aid primary care physicians in assessing memory complaints in people 60 and older. The company's technology is licensed from the University of North Texas Health Science Center research laboratory of Sid O'Bryant, PhD, the scientific fo

artificial intelligence predictive algorithmsblood-based biomarker diagnostics

Emery Pharma is a full-service Contract Research Organization (CRO) and GLP/cGMP-compliant contract research laboratory based in Alameda, California. It supports preclinical drug development with analytical and bioanalytical solutions, microbiology and cell biology services, drug and impurity characterization, and general R&D and cGMP/GLP support, delivering customized solutions to fit clients' outsourcing needs.

analytical method developmentbioanalytical assaysbiologics characterizationELISA and MSD immunoassaysGC-MSGLP/cGMP compliancehigh-resolution mass spectrometryHPLC/UPLCLC-MSLC-MS/MSmetabolomicsmethod transfermethod validationmicrobiology testingNMRstability testing

Emtherapro provides a next generation precision medicine enablement solution for neurodegenerative diseases, empowering biotech, life sciences and pharmaceutical companies to develop diagnostics and therapies. Anchored in proteomics, it integrates clinical, pathological, genetic and other omics data to advance biomarker discovery and validation for risk profiling, diagnosis, monitoring, prognosis and safety.

AIbiomarker identification and validationdrug engagement and dosage optimizationmachine learningMoA analysisomics data integrationparticipant screeningpre-clinical optimizationsystems biologytarget identification and validation

The European Molecular Biology Laboratory (EMBL) is an intergovernmental organisation headquartered in Heidelberg, founded in 1974 with the mission of promoting molecular biology research in Europe, training young scientists, and developing new technologies. Supported by more than 30 countries, it operates six sites in Barcelona, Grenoble, Hamburg, Heidelberg, EMBL-EBI Hinxton, and Rome, employing more than 1800 people and hosting more than 110 independent research groups and service teams.

bioinformaticschemical biologyelectron microscopyflow cytometrygenomicshigh-throughput crystallisationimagingin vivo gene editingIT serviceslight microscopymetabolomicsmobile laboratory servicesprotein expression and purificationscientific instrumentation workshopsstructural biologyX-ray beamlines

The Research Institute of Molecular Pathology (IMP) is a leading basic research institute. Its 13 research groups with scientists from 40 countries address fundamental questions in molecular biology. Funded primarily by Boehringer Ingelheim and with unconstrained academic freedom, the IMP is the ideal environment for curiosity-driven biomedical research. As part of Vienna Bio Center, the IMP is embedded in one of Europe’s biggest life science hubs with over 3,000 people working on life science research, education, and business. Endorsements of the IMP by some of the World's most distinguished molecular biologists demonstrate that the IMP is among leading institutes of its kind. Since the IMP’s establishment in 1985, scientists at the institute are addressing important problems in research areas including molecular and cellular biology; structural biology and biochemistry; gene.

bioinformatics data analysisflow cytometry and cell sortinghigh-performance computingmechanical engineering and prototypingmicroscopy and imagingmonoclonal antibody productionpeptide synthesisprotein production and purificationSanger sequencingtransgenic mouse production